Measles Market Size, Revenue Share, Drivers & Trends Analysis Till 2027
The
global measles market is expected to
grow at a CAGR of ~5.1 % during the forecast period.
Measles or
rubeola is a contagious viral infection majorly affects the respiratory system.
An infected person can release the pathogens into the air when they cough or
sneeze. The main symptom of measles is an itchy skin rash. The rash often
starts on the head and moves down the body. Other symptoms include fever,
cough, runny nose, and conjunctivitis. Measles is one of the leading causes of
death in children. According to the World Health Organization (WHO), in 2014,
114,900 global deaths related to measles was reported and that most of the
patients were under the age of 5. Increasing prevalence of the disease and
changing lifestyle are the major drivers for the growth of the market.
Moreover, increasing prevalence of immunological diseases and increasing government
support for research & development have fuelled the market growth. However,
high cost of the treatment may hinder the growth of the market over the review
period.
Request
Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/4449
Regional
Analysis
The
Americas account for a significant share of the market owing to the presence of
huge patient population with various diseases. According to the Autoimmune Registry,
in 2012, 14.7 million people in the US were suffering from autoimmune diseases.
Auto immune diseases is one of the major factors responsible for measles.
Additionally, high healthcare spending and increasing government support for
research & development have fueled the market growth in this region.
Europe
holds the second largest market, which is followed by Asia Pacific. Asia
Pacific is the fastest growing market for measles. Presence of huge population
base, rapidly developing economy, and presence of huge opportunity for the
development of the market have boosted the market growth. India and China are
the major contributor to the growth of the market owing to developing
healthcare sector and increasing health care expenditure.
The Middle
East & Africa holds the lowest share in the market due to limited
availability of medical facilities. UAE, Saudi Arabia, and Kuwait are expected
to drive the Middle East & African market. Whereas, the African region is
expected to witness a moderate growth.
Segmentation
The global
measles market has been segmented on the basis of types, treatment, and end
users.
On the
basis of type, the market is segmented into red measles and German measles.
On the
basis of treatment, the market is segmented into antibiotic treatment,
antiviral treatment, vaccine, and others. Vaccines are further segmented into
mumps measles rubella vaccine, live (MMR-II) & mumps measles rubella, and
varicella virus vaccine (Proquad).
On the
basis of end user, the market is segmented into hospital, clinics, and others.
Key
Players
Some of key
players profiled in the report are Abbott (US), Novartis AG (Switzerland),
Biomedical diagnostics (US), Johnson & Johnson Services, Inc. (US), Sanofi
(US), Merck & Co., Inc. (US), Serum Institute of India Pvt. Ltd. (India),
Bavarian Nordic (Denmark), MedImmune (US Astellas Pharma Inc. (Japan), CSL
Limited (Australia), Emergent BioSolutions Inc. (US), and GlaxoSmithKline plc
(US), and others.
Access
Report Details @ https://www.marketresearchfuture.com/reports/measles-market-4449
About
Market Research Future:
At Market
Research Future (MRFR), we enable our customers to unravel the complexity of
various industries through our Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), & Consulting Services. MRFR team have supreme
objective to provide the optimum quality market research and intelligence
services to our clients.
Have a Look at
Related Reports:
Liver Cirrhosis Treatment Market
Contact
us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson
Street, 5Th Floor,
New York,
New York 10013
United
States of America
+1 628 258
0071
Email:
sales@marketresearchfuture.com

Comments
Post a Comment